Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1700034

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Trastuzumab Deruxtecan
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make a comparative assessment of the adequacy of the reasons the (a) National Institute for Health and Care Excellence has been unable and (b) Scottish Medicines Consortium has been able to recommend Enhertu for use on the NHS.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	20959
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes authoritative, evidence-based recommendations for the National Health Service in England on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits. Decisions on the availability of medicines in Scotland are a matter for the devolved administration.</p><p>The NICE published guidance in 2021 and 2023 recommending Enhertu, also known as trastuzumab deruxtecan, for the treatment of NHS patients with HER2-positive breast cancer through the Cancer Drugs Fund, and it is now available to eligible NHS patients in England in line with the NICE’s recommendations.</p><p>The NICE is currently evaluating Enhertu for the treatment of metastatic HER2-low breast cancer, and has not yet published final guidance. Stakeholders have had an opportunity to appeal against the NICE’s draft recommendations, and the NICE will consider any appeals through the established process and publish final guidance in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 15:01:22 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3930 label Biography information for Caroline Lucas

1700037

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Consultants
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of NHS consultants carried out work in the private sector in the most recent financial year for which data is available.
	tabling member constituency	Knowsley
	tabling member printed	Sir George Howarth
	uin	20900
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The Department does not hold the information requested.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/04/2024 10:23:50 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	481 label Biography information for Sir George Howarth

1700068

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Trastuzumab Deruxtecan
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether NICE is taking steps to make Enhertu available to the National Health Service to treat incurable HER2-low secondary breast cancer.
	tabling member constituency	South Holland and The Deepings
	tabling member printed	Sir John Hayes
	uin	20865
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing guidance for the National Health Service on whether Enhertu can be recommended for routine NHS funding, based on an assessment of the costs and benefits. The NICE was unfortunately unable to recommend Enhertu as a clinically and cost-effective use of NHS resources in its final draft guidance published on 5 March 2024. Stakeholders have had an opportunity to appeal against the NICE’s draft recommendations, and the NICE will consider any appeals through the established process, and will publish final guidance in due course.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 15:03:45 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	350 label Biography information for Sir John Hayes

1700072

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an estimate of changes in numbers of people reporting (a) physical and (b) mental health issues in the week following clock changes in March for British Summer Time in the last three years.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	20905
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The Department has not made an estimate of the number of people, or changes to the number of people, reporting physical or mental health issues following the clock changes.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/04/2024 08:53:48 answering member 4492 label Biography information for Maria Caulfield
	tabling member	1409 label Biography information for Mr Gregory Campbell

1700124

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Protection (Notification) Regulations 2010
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what weighting her department is giving to (a) individual and (b) organisational stakeholder responses to the Health Protection (Notification) Regulations 2010 consultation.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	21001
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>The consultation on the Health Protection (Notification) Regulations 2010 closed in November 2023. As reflected in the published summary of responses, each response was treated equally during analysis, as is the standard approach for consultation response analysis. The Department and the UK Health Security Agency are considering the responses in total, and are grateful for the stakeholders’ engagement on this complex topic. Confirmation of any changes to the regulations will be published in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/04/2024 08:55:02 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4048 label Biography information for Caroline Nokes

1700176

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Pay
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason NHS employees in band 4 are only eligible for pay progression after three years, rather than two years as in other bands.
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	uin	21172
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>As part of the 2018 deal, all pay bands underwent a significant amount of structural reform. The reform included reducing the length of time it takes to reach the top of most pay bands, improving pay progression, and removing all overlap between pay bands. As such, the time taken to progress to the top of Band 4 has been reduced from six years to three years. The time taken to progress varies by band. This is to reflect the time needed to develop the knowledge and skills to perform at the top of the relevant band.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 17/04/2024 08:59:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4532 label Biography information for Derek Thomas

1700249

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Sodium Valproate: Compensation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing a response to the Hughes Report on compensation for patients damaged by sodium valproate, published 7 February 2024.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	21105
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Government commissioned the Patient Safety Commissioner (PSC) to produce a report on redress for those affected by sodium valproate and pelvic mesh. We are grateful to the PSC and her team for completing this report, and our sympathies remain with those affected by sodium valproate and pelvic mesh. The Government is now carefully considering the PSC’s recommendations, and will respond substantively in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 16/04/2024 13:36:40 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4418 label Biography information for Justin Madders

1700334

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has made a recent assessment of the potential merits of using breast density assessment software at women's first breast cancer screening appointments; and if she will make an assessment of the potential impact of that technology on women's awareness of their personal risk of developing breast cancer.
	tabling member constituency	North Warwickshire
	tabling member printed	Craig Tracey
	uin	21156
	answer	answer is ministerial correction date of answer 16/04/2024 answer text <p>The Breast Screening Risk Adaptive Imaging for Density trial is looking into the use of supplementary imaging techniques for women, within the standard breast screening programme, who are found to have radiographically dense breast tissue. The UK National Screening Committee, which advises ministers and the National Health Service in all four countries in the United Kingdom, will review this evidence when it becomes available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/04/2024 10:56:31 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4509 label Biography information for Craig Tracey

1700337

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Patients: Safety
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many never events occurred within NHS England in each year since 2019; and how many and what proportion of these incidents involved Physician Associates in each year.
	tabling member constituency	South Shields
	tabling member printed	Mrs Emma Lewell-Buck
	uin	21054
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>Information on Never Events is published by NHS England, and all available data on Never Events is available at the following link:</p><p><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.england.nhs.uk%2Fpatient-safety%2Fnever-events-data%2F&amp;data=05%7C02%7Cjonathan.stones%40dhsc.gov.uk%7C01ce069ba0534a13ed8d08dc5d394868%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638487747817797496%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=OXO3AEoXR3j0kiT5wETru35oEd3BrgsFWwvxdso0HI4%3D&amp;reserved=0" target="_blank">https://www.england.nhs.uk/patient-safety/never-events-data/</a></p><p>NHS England does not collect specific data relating to Physician Associate involvement in Never Events, and as such the information is not held.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/04/2024 08:58:36 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4277 label Biography information for Mrs Emma Lewell-Buck

1700424

	registered interest
	date	12/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Antibiotics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether officials in her Department have had recent discussions with the Care Quality Commission on antibiotic underdosing.
	tabling member constituency	Putney
	tabling member printed	Fleur Anderson
	uin	21311
	answer	answer is ministerial correction date of answer 17/04/2024 answer text <p>Officials from the Department have not had any recent discussions with the Care Quality Commission on antibiotic underdosing. General guidance on prescribing and the use of medicines is published online by the National Institute for Health and Care Excellence, and is available at the following link:</p><p><a href="https://bnf.nice.org.uk/" target="_blank">https://bnf.nice.org.uk/</a></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 17/04/2024 09:01:44 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4788 label Biography information for Fleur Anderson